XRCC1 and breast cancer: Although knocking out key BER factors such as Pol β and XRCC1 in mice often leads to embryonic lethality (9,10), cells of numerous different types of cancer tissues harbor mutated Pol β, and several XRCC1 polymorphisms have been associated with breast cancer or lung cancer in Asian patients (11,12).